Orthovanadate Decreases Leptin Secretion from Isolated Mouse Fat Pads.
-
- SUENAGA Tomohiro
- Department of Biochemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
-
- HIRANO Ken
- Department of Biochemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
-
- YOSHIDA Aya
- Department of Biochemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
-
- MOTOYASHIKI Toshio
- Department of Biochemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
-
- MORITA Tetsuo
- Department of Biochemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
-
- UEKI Hiroshi
- Department of Biochemistry, Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University
Search this article
Description
When isolated mouse fat pads were incubated with orthovanadate (vanadate) or insulin for up to 4 h, the leptin secretion into the medium was decreased by vanadate and increased by insulin. Propranolol, a nonspecific antagonist of β-adrenergic receptors, bupranorol, a specific antagonist of β3-adrenergic receptor, and H-89, an inhibitor of cAMP-dependent protein kinase (PKA) all inhibited the decrease by vanadate to various extents. In contrast, no inhibition was observed with specific antagonists of β1- and β2-adrenergic receptors or with inhibitors of protein kinase C and Ca/calmodulin kinase. Short-term incubation of the fat pads with vanadate showed a transient increase in the cellular cAMP content; this increase was inhibited by propranolol and bupranolol. Vanadate had no effect on the incorporation of [3H]-leucine into proteins of the fat pads with a 4-h incubation, although insulin stimulated the incorporation. The decreasing effect of vanadate on the leptin secretion seems to be independent of the regulation of protein synthesis. These results suggest that vanadate decreases the leptin secretion through mechanisms involving the increase in cellular cAMP content via β3-adrenergic receptor, probably leading to the activation of PKA.
Journal
-
- Biological and Pharmaceutical Bulletin
-
Biological and Pharmaceutical Bulletin 24 (4), 327-331, 2001
The Pharmaceutical Society of Japan
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204626285952
-
- NII Article ID
- 110003638465
-
- NII Book ID
- AA10885497
-
- COI
- 1:CAS:528:DC%2BD3MXisFals7k%3D
-
- ISSN
- 13475215
- 09186158
-
- NDL BIB ID
- 5727729
-
- PubMed
- 11305589
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- Abstract License Flag
- Disallowed